NEW YORK (GenomeWeb) – When he was first approached to head up the Japan Agency for Medical Research and Development (AMED), Makoto Suematsu was not interested. 

For years, an agency in Japan that would be the equivalent of the US National Institutes of Health had been proposed only to eventually evaporate into the mist. Besides, as Dean of the Keio University School of Medicine, Suematsu enjoyed the research aspect of his career and he was not looking to become a government bureaucrat. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.